Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)
Study sponsor: Mesoblast, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2011-05-18Actual
Enrollment · participants220Actual
Source updated2026-03-11Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.